DHX15 and neoplasm: Five weeks after injection, Dhx15+/− mice exhibited similar tumor size (Figure 5A, panels a and b) and low, nonsignificant expression levels of the HCC marker alpha-fetoprotein (AFP) compared to wild-type mice (Supplementary Figure S4A).